, Japan
/Ryoji Iwata from Unsplash

Nippon Life eyes $8.2b Resolution Life buyout

If finalised, the deal would be the largest overseas acquisition by a Japanese insurer.

Nippon Life Insurance is nearing the completion of a potential $8.2b acquisition of Bermuda-based Resolution Life Group Holdings, according to Resolution Life, reported Reuters.

If finalised, the deal would be the largest overseas acquisition by a Japanese insurer and underscores Japanese insurers’ pursuit of growth in foreign markets, particularly the United States.

The Nikkei business daily first reported the planned transaction, noting Nippon Life’s intention to buy out the remaining shares in Resolution Life from Blackstone and other stakeholders, making it a wholly owned subsidiary by the second half of 2025. 

The purchase will reportedly be funded using Nippon Life’s cash reserves.
whilst confirming ongoing discussions, Resolution Life stated that no agreement had been finalised and the outcome remained uncertain. 

Nippon Life also acknowledged the talks but refrained from providing specific details. Blackstone declined to comment on the report.

This acquisition marks Nippon Life’s second major overseas investment in 2024, following its $3.8b purchase of a 20% stake in US insurer Corebridge Financial in May. 
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.